Headquartered in Hong Kong, NT Pharma is a leading service provider of manufacturing, distribution, sales & promotion, and logistics of pharmaceutical products in China. NT Pharma is privately held and has recently invited TPG, a leading global private investment firm, as a strategic investor into the Company. Backed by TPG’s financial strength and industry expertise in the global healthcare sector, this strategic alliance will be instrumental for NT Pharma’s rapid growth in the coming years.

About TPG

　　TPG is a private investment firm that was founded in 1992 and currently has more than US$50 billion of assets under management. Through its investment platforms, TPG Capital and TPG Growth, the firm has extensive experience with global public and private investments executed through leveraged buyouts, recapitalizations, spinouts, joint ventures, growth investments and restructurings. TPG is also associated with TPG Axon Capital and TPG Credit Management. The firm is headquartered in Fort Worth, and has offices in San Francisco, London, Hong Kong, New York, Minneapolis, Melbourne, Menlo Park, Moscow, Mumbai, Beijing, Shanghai, Singapore and Tokyo.